Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지
DOI QR코드

DOI QR Code

Current Research Trend of Herbal Medicine in Pharmacoepidemiology

약물역학분야의 한약연구동향

  • Woo, Yeonju (Institute of Korean Medical Science, Pusan National University)
  • 우연주 (부산대학교 한의과학연구소)
  • Received : 2018.10.22
  • Accepted : 2018.12.11
  • Published : 2018.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The aim of this study is to investigate the current research trend of herbal medicine based on the published articles in pharmacoepidemiologic journals. Methods : A total of 3 electronic journals, Pharmacoepidemiology and Drug Safety(PDS), Drug Safety and Journal of Pharmacoepidemiology and Risk Management(JPERM) from January 2013 to August 2018 were used for searching articles about herbal medicine. Selected articles were reviewed and classified under 5 categories-collection of adverse events in herbal medicine, statistical modeling and methodology, pharmaco-epidemiologic outcome study, drug utilization review(DUR), risk management system and regulation. Results : A total of 8 articles were finally included for analysis. 2 articles were categorized in collection of adverse events in herbal medicine, 1 was statistical modeling and methodology, 2 were pharmacoepidemiologic outcome study and 3 were risk management system and regulation. There was no article in DUR. And then pharmacoepidemiologic research trends of herbal medicine were summarized in classification of 5 categories. Conclusions : To sum up with these 8 articles of herbal medicine in pharmacoepidemiologic journals, herbal medicine was of interesting concern among researchers. The need for research on safety and risk management of herbal medicine is steadily increasing, pharmacoepidemiologic research about herbal medicine must be activated in Korea.

Keywords

References

  1. Park B, Pharmacoepidemioogy 2nd ed. Seoul National University Press. 2012.
  2. Strom B, Pharmacoepidemiology 4th ed. John Wiley. 2005.
  3. WHO, The Importance of Pharmacovigilance-Safety Monitoring of Medicinal Products. World Health Organization. 2002.
  4. ISPE. Available from: http://www.pharmacoepi.org.
  5. ISoP. Available from: http://www.isoponline.org.
  6. KoPERM. Available from: http://www.koperm.org.
  7. Rodrigues E, Barnes J, Pharmacovigilance of herbal medicines: the potential contributions of ethnobotanical and ethnopharmacological studies. Drug safety, 2013;36(1):1-12.
  8. Park JH, Choi SM, Moon S, Kim S, Kim B, Kim MK, et al., Development of an adverse events reporting form for Korean folk medicine. Pharmacoepidemiology and drug safety, 2017;26(5):498-508. https://doi.org/10.1002/pds.4077
  9. Yang HC, Iqbal U, Nguyen PA, Lin SH, Huang CW, Jian WS, et al., An automated technique to identify potential inappropriate traditional Chinese medicine (TCM) prescriptions. Pharmacoepidemiology and drug safety, 2016;25(4):422-30. https://doi.org/10.1002/pds.3976
  10. Lind JN, Tinker SC, Broussard CS, Reefhuis J, Carmichael SL, Honein MA, et al., Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiology and drug safety, 2013;22(7):783-93. https://doi.org/10.1002/pds.3448
  11. Vega M, Verma M, Beswick D, Bey S, Hossack J, Merriman N, et al., The Incidence of Drugand Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware. Drug safety, 2017;40(9):783-7. https://doi.org/10.1007/s40264-017-0547-9
  12. Liu SH, Chuang WC, Lam W, Jiang Z, Cheng YC, Safety surveillance of traditional Chinese medicine: current and future. Drug safety, 2015;38(2):117-28. https://doi.org/10.1007/s40264-014-0250-z
  13. Yuan P, Zhu H, Wang L, Herbal medicine: abuse and risk in China. Pharmacoepidemiology and drug safety, 2016;25(5):606. https://doi.org/10.1002/pds.3997
  14. Choi H, The Internal Current Status and Prospect of Reports of Adverse Drug Reactions of Herbal Medicine: The Necessity of Report of Adverse Drug Reactions of Herbal Medicine and Henceforth Task. JPERM, 2018;10:1-8.
  15. CIOMS, Practical Aspects of Signal Detection in Pharmacovigilance. Council for International Organization of Medical Sciences. 2010.
  16. ICH, Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs) E2B(R3) Data Elements and Message Specification. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. 2016.
  17. Shmueli G, Patel N, Bruce PC, Datamining for Business Intelligence 2nd ed. John Wiley. 2010.
  18. Nguyen PA, Syed-Abdul S, Iqbal U, Hsu MH, Huang CL, Li HC, et al., A probabilistic model for reducing medication errors. PloS one, 2013;8(12):e82401. https://doi.org/10.1371/journal.pone.0082401
  19. McBride WG, Thalidomide and congenital abnormalities. Lancet, 1961;2(1358):90927-8.
  20. Herbst AL, Ulfelder H, Poskanzer DC, Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. The New England journal of medicine, 1971;284(15):878-81. https://doi.org/10.1056/NEJM197104222841604
  21. Satoh H, Pharmacological characteristics of Kampo medicine as a mixture of constituents and ingredients. Journal of integrative medicine, 2013;11(1):11-6. https://doi.org/10.3736/jintegrmed2013003
  22. Lee S, Park Y, Toxicology for herbal medicine I. Korean Studies Information. 2012.
  23. Kim M, Han CH, Analysis of herbal-drug-associated adverse drug reactions using data from spontaneous reporting system in electronic medical records. Journal of Korean Medicine, 2015;36(1):45-60. https://doi.org/10.13048/jkm.15005
  24. Park B, Drug utilization review. J Pharmacoepidemiol Risk Manag, 2008;1:13-9.
  25. Harris PE, Cooper KL, Relton C, Thomas KJ, Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. International journal of clinical practice, 2012;66(10):924-39. https://doi.org/10.1111/j.1742-1241.2012.02945.x
  26. Heiligers PJ, de Groot J, Koster D, van Dulmen S, Diagnoses and visit length in complementary and mainstream medicine. BMC complementary and alternative medicine, 2010;10:3. https://doi.org/10.1186/1472-6882-10-3
  27. Baars E. Complementary and Alternative Medicine - Innovation and Added Value for European Healthcare. in Complementary and Alternative Medicine and Chronic Disease Management. European Parliament Conference. 2012. Brussels.